YM155, a novel small molecule survivin suppressant, exhibits curative antitumor activities in experimental human malignant lymphoma models in vivo

被引：1
作者：
Kita, A.
Nakahara, T.
Yamanaka, K.
Koutoku, H.
Takeuchi, M.
Kinoyama, I.
Matsuhisa, A.
Sasamata, M.
机构：
[1] Astellas Pharma Inc, Pharmacol Res Labs, Tsukuba, Ibaraki, Japan
[2] Astellas Pharma Inc, Mol Med Res Labs, Tsukuba, Ibaraki, Japan
[3] Astellas Pharma Inc, Chem Res Labs, Tsukuba, Ibaraki, Japan
来源：
EJC SUPPLEMENTS | 2006年 / 4卷 / 12期
关键词：
D O I：
10.1016/S1359-6349(06)70382-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
377
引用
收藏
页码：116 / 116
页数：1
相关论文
共 46 条
[41]   DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo [J].
Li, Meng-yuan ;
Lv, Yong-cong ;
Tong, Lin-jiang ;
Peng, Ting ;
Qu, Rong ;
Zhang, Tao ;
Sun, Yi-ming ;
Chen, Yi ;
Wei, Li-xin ;
Geng, Mei-yu ;
Duan, Wen-hu ;
Xie, Hua ;
Ding, Jian .
ACTA PHARMACOLOGICA SINICA, 2016, 37 (03) :398-407
[42]   Sepantronium Bromide (YM155), A Small Molecule Survivin Inhibitor, Promotes Apoptosis by Induction of Oxidative Stress, Worsens the Behavioral Deficits and Develops an Early Model of Toxic Demyelination: In Vivo and In-Silico Study [J].
Reiszadeh-Jahromi, Samaneh ;
Sepand, Mohammad-Reza ;
Ramezani-sefidar, Samaneh ;
Shahlaei, Mohsen ;
Moradi, Sajad ;
Yazdankhah, Meysam ;
Sanadgol, Nima .
NEUROCHEMICAL RESEARCH, 2019, 44 (11) :2482-2498
[43]   Sepantronium Bromide (YM155), A Small Molecule Survivin Inhibitor, Promotes Apoptosis by Induction of Oxidative Stress, Worsens the Behavioral Deficits and Develops an Early Model of Toxic Demyelination: In Vivo and In-Silico Study [J].
Samaneh Reiszadeh-Jahromi ;
Mohammad-Reza Sepand ;
Samaneh Ramezani-sefidar ;
Mohsen Shahlaei ;
Sajad Moradi ;
Meysam Yazdankhah ;
Nima Sanadgol .
Neurochemical Research, 2019, 44 :2482-2498
[44]   Carrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma Cells [J].
Minematsu, Tsuyoshi ;
Iwai, Megumi ;
Sugimoto, Kenji ;
Shirai, Nobuaki ;
Nakahara, Takahito ;
Usui, Takashi ;
Kamimura, Hidetaka .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (03) :619-628
[45]   Involvement of Human Organic Cation Transporter 1 in the Hepatic Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel, Small Molecule Survivin Suppressant [J].
Iwai, Megumi ;
Minematsu, Tsuyoshi ;
Narikawa, Shinichi ;
Usui, Takashi ;
Kamimura, Hidetaka .
DRUG METABOLISM AND DISPOSITION, 2009, 37 (09) :1856-1863
[46]   Characterization of Human Organic Cation Transporter 1 (OCT1/SLC22A1)- and OCT2 (SLC22A2)-Mediated Transport of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho[2,3-d]imidazolium Bromide (YM155 Monobromide), a Novel Small Molecule Survivin Suppressant [J].
Minematsu, Tsuyoshi ;
Iwai, Megumi ;
Umehara, Ken-Ichi ;
Usui, Takashi ;
Kamimura, Hidetaka .
DRUG METABOLISM AND DISPOSITION, 2010, 38 (01) :1-4
12345